Press Releases

2013 Geoffrey Beene Global NeuroDiscovery Challenge

Crowdvoting by Scientists and Public Determines

Round Two Winners of $50,000 21 CBT Innovation

Enrico Glaab, Ph.D., focuses on male-specific gene to unlock sex-based differences in the diagnosis and treatment of Alzheimer’s disease 

‘Path to 2025’ Alzheimer’s Disease Summit: Reforms Urgently Needed to Streamline Road to Alzheimer’s Prevention and Treatment as Global Prevalence is Set to Triple

New Report Provides Specific Recommendations for Governments, Academia, and Industry to Reduce Costs and Increase Efficiency in Alzheimer’s R&D so New Drugs Reach Patients Faster and Health Systems Save Billions

Dr. Peter L. Levin, Blue Button Healthcare Innovator, Joins USAgainstAlzheimer's Network

USAgainstAlzheimer’s Network Strengthens Innovation Capacity in Race to Stop Alzheimer’s by 2025

WASHINGTON, D.C. – The USAgainstAlzheimer's Network today announced that Dr. Peter L. Levin, developer of Blue Button personal health record technology during his role as Chief Technology Officer for the U.S. Department of Veteran Affairs, will join the USAgainstAlzheimer’s Network’s Board.

Jeff Eller, Communications Strategist, Joins USAgainstAlzheimer's Board

USAgainstAlzheimer’s Strengthens Role in Advancing Alzheimer’s Solutions

WASHINGTON, D.C. – USAgainstAlzheimer's today announced that Jeff Eller, chairman of Public Strategies, Inc. and former Deputy Assistant to the President and Director of Media Affairs in the Clinton Administration, will join USAgainstAlzheimer’s Board.

USAgainstAlzheimer’s Disappointed with Medicare’s Final Decision To Limit Coverage of Innovative Diagnostic Tool

Despite public protest, decision will bar thousands of Alzheimer’s and dementia patients from access to PET beta-amyloid scans that help optimize diagnoses



^ Back to Top